CANC vs. MBCC ETF Comparison

Comparison of Tema Oncology ETF (CANC) to Monarch Blue Chips Core ETF (MBCC)
CANC

Tema Oncology ETF

CANC Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$29.23

Average Daily Volume

5,573

Number of Holdings *

7

* may have additional holdings in another (foreign) market
MBCC

Monarch Blue Chips Core ETF

MBCC Description The investment seeks to replicate investment results that generally correspond, before fees and expenses, to the performance of the Kingsview Blue Chips Core Index. The fund generally invests at least 80% of its total assets in the component securities of the index. The index consists of established, well-recognized companies listed on the S&P 500 from a broad range of industries that demonstrate strength in the marketplace based on fundamental company data such as revenue, revenue growth, net income, and net income growth.

Grade (RS Rating)

Last Trade

$34.73

Average Daily Volume

11,241

Number of Holdings *

24

* may have additional holdings in another (foreign) market
Performance
Period CANC MBCC
30 Days -1.45% 2.69%
60 Days -0.07% 5.82%
90 Days 7.07% 4.89%
12 Months 26.15% 32.43%
2 Overlapping Holdings
Symbol Grade Weight in CANC Weight in MBCC Overlap
AMGN B 3.78% 4.09% 3.78%
MRK D 4.26% 4.02% 4.02%
CANC Overweight 5 Positions Relative to MBCC
Symbol Grade Weight
REGN C 6.07%
ARGX C 4.19%
BPMC D 3.3%
ILMN C 3.27%
RVMD C 3.13%
CANC Underweight 22 Positions Relative to MBCC
Symbol Grade Weight
ORCL B -4.72%
AMT C -4.38%
AMZN C -4.33%
V C -4.27%
COST B -4.24%
MSFT C -4.23%
ADBE F -4.22%
MA B -4.21%
DHR C -4.19%
MCD B -4.19%
META A -4.17%
CRM D -4.14%
NVDA D -4.13%
TMO C -4.13%
DIS D -4.09%
BKNG B -4.09%
NFLX B -4.05%
LLY C -4.03%
GE A -4.02%
BRK.A C -3.92%
NKE D -3.89%
TXN C -3.78%
Compare ETFs